artenimol has been researched along with Cancer of Cervix in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| An, S; Dong, L; Jia, X; Jiang, X; Wang, C; Xu, Z; Zhang, W; Zhen, W | 1 |
| Tang, T; Xi, M; Xia, Q | 1 |
| Cai, P; Hu, Y; Wang, T; Zhang, T | 1 |
| Li, H; Li, J; Li, S; Li, Z; Shi, X; Tang, PM; Wang, L; Wei, C | 1 |
| Cao, J; Chen, G; Chen, X; Ling, Y; Lu, X; Luo, J; Zhang, S; Zhou, X; Zhu, W | 1 |
| Cai, Y; Hu, CJ; Zhou, L | 1 |
| Baege, AC; Centeno, JA; Disbrow, GL; Hartmann, D; Kierpiec, KA; Schlegel, R; Thibodeaux, CA; Yuan, H | 1 |
7 other study(ies) available for artenimol and Cancer of Cervix
| Article | Year |
|---|---|
Biodegradable iron-coordinated hollow polydopamine nanospheres for dihydroartemisinin delivery and selectively enhanced therapy in tumor cells.
Topics: Animals; Antimalarials; Apoptosis; Artemisinins; Cell Proliferation; Drug Delivery Systems; Female; Humans; Indoles; Iron; Mice; Nanospheres; Polymers; Reactive Oxygen Species; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Dihydroartemisinin and its anticancer activity against endometrial carcinoma and cervical cancer: involvement of apoptosis, autophagy and transferrin receptor.
Topics: Apoptosis; Artemisinins; Autophagy; Cell Line, Tumor; Endometrial Neoplasms; Female; Humans; Receptors, Transferrin; Uterine Cervical Neoplasms | 2021 |
Dihydroartemisinin inhibits the viability of cervical cancer cells by upregulating caveolin 1 and mitochondrial carrier homolog 2: Involvement of p53 activation and NAD(P)H:quinone oxidoreductase 1 downregulation.
Topics: Artemisinins; Caveolin 1; Cell Survival; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Mitochondrial Membrane Transport Proteins; NAD(P)H Dehydrogenase (Quinone); Tumor Suppressor Protein p53; Up-Regulation; Uterine Cervical Neoplasms | 2017 |
Antimalarial Dihydroartemisinin triggers autophagy within HeLa cells of human cervical cancer through Bcl-2 phosphorylation at Ser70.
Topics: Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Autophagy; bcl-2 Homologous Antagonist-Killer Protein; Beclin-1; Cisplatin; DNA Breaks, Double-Stranded; Female; HeLa Cells; Humans; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; TOR Serine-Threonine Kinases; Up-Regulation; Uterine Cervical Neoplasms | 2019 |
Dihydroartemisinin induces radiosensitivity in cervical cancer cells by modulating cell cycle progression.
Topics: Artemisinins; Cell Division; Female; G2 Phase; HeLa Cells; Humans; Radiation Tolerance; Uterine Cervical Neoplasms | 2013 |
Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphatidylethanolamine Binding Protein; Proto-Oncogene Proteins c-bcl-2; Tumor Burden; Up-Regulation; Uterine Cervical Neoplasms | 2014 |
Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo.
Topics: Animals; Apoptosis; Artemisinins; Dogs; Epithelial Cells; Female; HeLa Cells; Humans; Mitochondria; Mouth Mucosa; Papillomaviridae; Papillomavirus Infections; Reactive Oxygen Species; Sesquiterpenes; Uterine Cervical Neoplasms; Virus Replication | 2005 |